Department of Medicine

Russell Rothman, MD, MPP, speaks at last week’s MidSouth Practice Transformation Network (PTN): Vanderbilt Health Affiliated Network Summer Summit.
July 25, 2019

Summit highlights clinical improvement successes

A summit at Vanderbilt reviewed achievements of an ongoing regional effort to transform clinical practices in ways that would improve the quality of patient care, reduce costs and improve health outcomes

By Jill Clendening
July 25, 2019

Sex differences in kidney injury

Men are more susceptible to progressive kidney disease than women; new VUMC studies point to differences in the expression and activation of the EGF receptor.

By Kelsey Herbers
July 22, 2019

Encephalitis identified as rare toxicity of immunotherapy treatment

Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.

By Tom Wilemon
July 18, 2019

Madhur receives Presidential Early Career Award

Meena Madhur, MD, PhD, has received a Presidential Early Career Award for Scientists and Engineers.

By Leigh MacMillan
July 18, 2019

Genetic characteristics of peripheral artery disease studied

New study explores why some people with peripheral artery disease present with problems with their legs, some with their heart and some with strokes.

By Matt Batcheldor
July 18, 2019

Effort seeks to improve safety of drugs given during pregnancy

A 19-year-old student is leading a multi-institutional collaboration to identify drugs that can be prescribed safely to pregnant women without harming the fetus.

By Bill Snyder
July 11, 2019

Vanderbilt team shows how stomach bug can trigger cancer

Researchers at Vanderbilt University and the University of Michigan in Ann Arbor have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori (H. pylori) to inject a cancer-causing protein into the stomach lining.
By Bill Snyder
July 8, 2019

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
By Leigh MacMillan
June 27, 2019

Health disparity for black people exists within lung screening guidelines

By Tom Wilemon
June 26, 2019

Biomarkers of DNA methylation can be a predictor of breast cancer risk

Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.
By Tom Wilemon
June 20, 2019

Microbiome links diet to health

Vanderbilt researchers have discovered that the gut microbiome composition modulates how dietary nutrients are metabolized, with potential downstream consequences on metabolic health.
By VUMC News and Communications
June 18, 2019

Study identifies critical regulator of tumor-specific T cell differentiation

A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work
By Tom Wilemon
June 13, 2019

Eng named to GI cancer leadership position at VICC

Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC).
By Tom Wilemon
1 … 65 66 67 68 69 … 116